AC
Aristeia Capital’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-70,959
| Closed | -$102K | – | 520 |
|
|
2025
Q1 | $102K | Hold |
70,959
| – | – | ﹤0.01% | 335 |
|
|
2024
Q4 | $156K | Hold |
70,959
| – | – | 0.01% | 281 |
|
|
2024
Q3 | $117K | Hold |
70,959
| – | – | ﹤0.01% | 251 |
|
|
2024
Q2 | $158K | Hold |
70,959
| – | – | ﹤0.01% | 222 |
|
|
2024
Q1 | $190K | Hold |
70,959
| – | – | ﹤0.01% | 169 |
|
|
2023
Q4 | $212K | Hold |
70,959
| – | – | ﹤0.01% | 79 |
|
|
2023
Q3 | $69.5K | Hold |
70,959
| – | – | ﹤0.01% | 124 |
|
|
2023
Q2 | $98.6K | Hold |
70,959
| – | – | ﹤0.01% | 139 |
|
|
2023
Q1 | $113K | Hold |
70,959
| – | – | ﹤0.01% | 226 |
|
|
2022
Q4 | $442K | Sell |
70,959
-44,992
| -39% | -$280K | 0.01% | 320 |
|
|
2022
Q3 | $777K | Hold |
115,951
| – | – | 0.01% | 402 |
|
|
2022
Q2 | $737K | Hold |
115,951
| – | – | 0.01% | 381 |
|
|
2022
Q1 | $538K | Hold |
115,951
| – | – | 0.01% | 394 |
|
|
2021
Q4 | $580K | Buy |
115,951
+48,258
| +71% | +$241K | 0.01% | 425 |
|
|
2021
Q3 | $816K | Buy |
+67,693
| New | +$816K | 0.02% | 351 |
|